Related content

The use of in vivo zebrafish assays in drug toxicity screening

By Eimon Peter M   Rubinstein Amy L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 393-401

Informa Healthcare

Access to resources Recommend Favorite

Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models

By Sukardi Hendrian   Chng Hui Ting   Chan Eric Chun Yong   Gong Zhiyuan   Lam Siew Hong  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 579-589

Informa Healthcare

Access to resources Recommend Favorite

Cardiac arrhythmia: in vivo screening in the zebrafish to overcome complexity in drug discovery

By MacRae Calum A  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 7, 2010-07 ,pp. : 619-632

Informa Healthcare

Access to resources Recommend Favorite

Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity

By de Campos Angela M.   Diebold Yolanda   Carvalho Edison L. S.   Sánchez Alejandro   José Alonso Maria  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 803-810

Springer Publishing Company

Access to resources Recommend Favorite

The role of early in vivo toxicity testing in drug discovery toxicology

By Fielden Mark R   Kolaja Kyle L  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 107-110

Informa Healthcare

Access to resources Recommend Favorite